Suntory Invests £14.5m to Strengthen UK Blackcurrant Supply Chain and Future-Proof Ribena Production
Suntory Beverage & Food GB&I has invested £14.5 million in a new blackcurrant processing facility designed to strengthen…
HARIBO Invests £35 Million to Expand UK Manufacturing and Distribution Capacity
New Castleford warehouse and production line strengthen supply chain resilience and support future confectionery growth for HARIBO HARIBO…
Why AMD is Planning a £2 Billion UK Investment in AI Research and Computing
Over the next five years, AMD will invest substantially in advanced AI research and computing in the UK,…
LEGO Group’s Biggest Solar Project Yet Shows Renewable Energy Can Deliver More Than Decarbonisation
The LEGO Group has started construction on its largest solar park to date near its Billund headquarters, combining…
Mondelēz Drives UK Growth Agenda
Mondelēz International has revealed a £2.3 billion contribution to the UK economy, urging the government to prioritise food…
Pharma’s AI Investment Signals New Drug Discovery Paradigm
From improved molecular design to AI-driven automation, waves of AI tools promise to accelerate therapeutic development. Still, skeptics…
how young Aussies are navigating money in 2026
The poll, run by The Daily Aus in partnership with CommBank Newsroom, shows housing was the most commonly cited savings priority. Travel and…
Outfielder Tries the Dirt at Keeneland
Outfielder | Katie Petrunyak By Alan Carasso 3rd-KEE, $120k, Alw (N2L), 2yo, 6f, post time: 2:04 p.m. ETAmo…
Investment Opportunities in Saudi Arabia Ice Cream Market: Industry Insights & Projections
Saudi Arabia Ice Cream Market Overview
Market Size in 2024: USD 787 Million
Market Size in 2033: USD…
![An AI-designed protein binder (purple and pink) envelops the flexible hormone amylin (white), preventing it from forming toxic fibrils linked to type 2 diabetes in lab tests. [Ian Haydon]](https://www.newsbeep.com/uk/wp-content/uploads/2025/07/diffused-amylin-binder-UW-IPD-380x220.jpg)
AI Hits Disordered Proteins, Unlocks Therapy Targets
Drug developers have historically glued their attention to targeting the precise and fine-tuned protein structures underlying biological function.…